Evidence map›Paper›PMID 24465879›Full record

ArticlePloS one2014

Isolation and characteristics of Shiga toxin 2f-producing Escherichia coli among pigeons in Kyushu, Japan.

Koichi Murakami, Yoshiki Etoh, Sachiko Ichihara, Eriko Maeda, Shigeyuki Takenaka, Kazumi Horikawa, Hiroshi Narimatsu, Kimiko Kawano, Yoshiaki Kawamura, Kenitiro Ito

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Recent Updates on Outbreaks of Shiga Toxin-ProducingFrontiers in cellular and infection microbiology · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Novel Hybrid of Typical EnteropathogenicFrontiers in microbiology · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Koichi MurakamiDepartment of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Yoshiki EtohDepartment of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Sachiko IchiharaDepartment of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Eriko MaedaDepartment of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Shigeyuki TakenakaDepartment of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Kazumi HorikawaDepartment of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Hiroshi NarimatsuLaboratory of Microbiology, Oita Prefectural Institute of Health and Environment, Oita, Oita, Japan.
Kimiko KawanoMiyazaki Prefectural Institute for Public Health and Environment, Miyazaki, Miyazaki, Japan.
Yoshiaki KawamuraDepartment of Microbiology, School of Pharmacy, Aichi Gakuin University, Chikusa-ku, Nagoya, Aichi, Japan.
Kenitiro ItoNational Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Fukuoka Institute of Health and Environmental Sciences · JPAichi Gakuin University · JPMiyazaki Prefectural Hospital · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing number of Shiga toxin 2f-producing Escherichia coli (STEC2f) infections in humans are being reported in Europe, and pigeons have been suggested as a reservoir for the pathogen. In Japan, there is very little information regarding carriage of STEC2f by pigeons, prompting the need for further investigation. We collected 549 samples of pigeon droppings from 14 locations in Kyushu, Japan, to isolate STEC2f and to investigate characteristics of the isolates. Shiga toxin stx 2f gene fragments were detected by PCR in 16 (2.9%) of the 549 dropping samples across four of the 14 locations. We obtained 23 STEC2f-isolates from seven of the original samples and from three pigeon dropping samples collected in an additional sampling experiment (from a total of seven locations across both sampling periods). Genotypic and phenotypic characteristics were then examined for selected isolates from each of 10 samples with pulsed-field gel electrophoresis profiles. Eight of the stx 2f gene fragments sequenced in this study were homologous to others that were identified in Europe. Some isolates also contained virulence-related genes, including lpfA O26, irp 2, and fyuA, and all of the 10 selected isolates maintained the eae, astA, and cdt genes. Moreover, five of the 10 selected isolates contained sfpA, a gene that is restricted to Shiga toxin-producing E. coli O165:H2 and sorbitol-fermenting Shiga toxin-producing E. coli O157:NM. We document serotypes O152:HNM, O128:HNM, and O145:H34 as STEC2f, which agrees with previous studies on pigeons and humans. Interestingly, O119:H21 was newly described as STEC2f. O145:H34, with sequence type 722, was described in a German study in humans and was also isolated in the current study. These results revealed that Japanese zoonotic STEC2f strains harboring several virulence-related factors may be of the same clonal complexes as some European strains. These findings provide useful information for public health-related disease management strategies in Japan.

Indexed as

AnimalsBird DiseasesColumbidaeDisease ReservoirsEscherichia coli InfectionsFecesIncidenceJapanMultilocus Sequence TypingPhylogenyShiga-Toxigenic Escherichia coliShiga Toxin 2Shiga Toxin 2

Identifiers

PMID24465879
PMCPMC3900449
OpenAlexW2165305935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.